Publications
The NYC Health Department recently released the 2018 version of City Health Information (CHI): Preventing, Identifying, and Managing Hepatitis B Virus Infection.
Publications
The NYC Health Department recently released the 2018 version of City Health Information (CHI): Diagnosing & Managing Hep C providing guidance to Primary Care Providers in hepatitis C screening, management and treatment.
The primary goals of the Manual are to increase advocates' knowledge about available HCV tests and treatments and to jumpstart discussions on advocacy strategies that can be used to open up affordable access for more people with HCV.
The American College of Physicians' High Value Care Task Force and the Centers for Disease Control and Prevention developed this article to present best practice statements for hepatitis B vaccination, screening, and linkage to care.
This study aims to validate algorithms designed to estimate treatment and cure of Hep C using RNA test results reported through routine surveillance.
Learn about key clinical updates in Hepatitis C presented at recent conferences.
The researchers found anti-HCV antibody in 372 of 4,989 participants (7.5%) with completed results. The confirmatory test showed HCV RNA positive in 196 individuals—38 of which (19.2%) of which were undiagnosed. There was also a substantial number of coinfections in the cohort....
This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
In recognition of Liver Cancer Awareness Month, Gilead Sciences is excited to share that you can now watch BE ABOUT IT – the documentary highlighting the impact of chronic hep B on the Asian American community – on the Gilead YouTube channel!
Examining Hepatitis C Virus Treatment Access: A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
